The cost-effectiveness of managed care regarding chronic medicine prescriptions in a selected medical scheme.
The purpose of the study was to examine the cost-effectiveness of managed care interventions with respect to prescriptions for chronic illness sufferers enrolled with a specific medical scheme. The illnesses included, were epilepsy, hypertension, diabetes and asthma. The managed care interventions applied were a primary discount; the use of preferred provider pharmacies, and drug utilization review. It was concluded that the managed care interventions resulted in some real cost savings.
Day
K
K
Booyens
S
S
D001249:Asthma / Q000188:drug therapy; D002908:Chronic Disease / Q000188:drug therapy*; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D003920:Diabetes Mellitus / Q000188:drug therapy; D016527:Drug Costs / Q000706:statistics & numerical data*; D011307:Drug Prescriptions / Q000191:economics*; D017723:Drug Utilization Review; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008329:Managed Care Programs / Q000458:organization & administration*; D015397:Program Evaluation; D013019:South Africa